Abstract
There are millions of surgical procedures performed annually worldwide and the
market for wound care products and techniques is significant. In the United
States alone, there are over 100,000 surgeries performed daily. Surgical and
trauma wounds are, by far, the most common types of wounds addressed in the
wound care area. Enjoying market success depends on several factors.
Manufacturers must develop a formidable strategy, which involves matching
internal capabilities with external opportunities. By choosing to implement
such strategies, providers are able to achieve high levels of clinical success
while controlling use and costs. Manufacturers are continuing to create
well-rounded and advanced products to provide a wider variety of choices. The
aging of the population and continued advances in biotechnology drive the
wound care industry. The aging world population created increased demand for
all types of surgical intervention, particularly cardiovascular, orthopedic,
urological and dermatological procedures. The emerging generation of wound
care products and technologies are well-positioned to capitalize on this
growth. Besides the always-improving synthetic dressing materials, newer
technologies in wound treatment include the xenogeneic tissue scaffold,
bilayered human dermal substitutes, recombinant growth factors, endoscopic
subfascial ligation of venous perforators, and endovascular arterial repair
techniques. New wound care products and devices are entering the market with
lightening speed, all striving for the best clinical outcomes.
Wound Care, 3rd. Edition, Vol. III: Surgical and Trauma Wounds details total
manufacturers' revenues from the following product categories:
- Wound Closure
- Sutures
- Staples
- Tissue adhesives, sealants and glues
- Anti-infectives
- Surgical and trauma wound management
- Wound cleaners
- Debridement
- Tapes
- Dry dressings
- Moist Dressings
- Alginates
- Films
- Foams
- Hydrocolloids
- Hydrogels
- Biological Dressings
- Artificial Skin
- Collagen
- Growth Factors
- Miscellaneous Treatments
The information and analysis presented in this report are based on an
extensive survey of senior management in the prescription women' s health drug
industry. Background information was obtained from a comprehensive search of
published literature and reports obtained from various government, business,
medical trade, and international journals. Key information from published
literature was used to conduct interviews with industry executives and product
managers to validate and obtain expert opinion on current and future trends in
the women' s health industry.
Interviews were also used to confirm and/or adjust market size and market
share estimates, as well as in formulating market projections. All market data
pertains to the U.S. market at the manufacturers' level. Revenues in the
report are based on sales at the manufacturers' level for the following
markets:
- Wound Closure
- Anti-infectives
- Surgical and Trauma Wound Management
- Moist Dressings
- Biological Dressings
- Miscellaneous Surgical Wound and Trauma Treatments
The market is varied in terms of both product offerings and product maturity.
Several of the segments are mature such as anti-infectives, wound management,
and sutures and staples of the wound closure market, while others such as
biological dressings, some moist dressings, and sealants, adhesives, and glues
of the wound closure segment are in the infant stages of development.
Thus some segments within the market are slowing in growth rates while others
are driving growth. As identified in the report, conventional, mature products
continue to generate the majority of sales; however, their growth rate is slow
and limited by the maturity of the product and the competition. Advancements
in technology are expected to drive growth during the forecast period.
Product Managers, Marketing Directors in the wound care industry as well as
financial and consulting executives are among those that will find this a
useful resource.
View Cart
